[Clinical significance of alpha 1-proteinase inhibitor in myocardial infarct]. 1989

I I Miagkov, and V R Trotsiuk

The authors analyze data of determination of alpha 1 proteinase inhibitor in patients with myocardial infarction depending on the severity of the disease. It is suggested that the quantitative values of alpha 1 proteinase inhibitors of the blood plasma may be used in the diagnosis and prognosis of the disease in the sense of correction inhibitor therapy and individual management.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

I I Miagkov, and V R Trotsiuk
December 1989, Nihon rinsho. Japanese journal of clinical medicine,
I I Miagkov, and V R Trotsiuk
January 1984, Advances in experimental medicine and biology,
I I Miagkov, and V R Trotsiuk
March 2010, P & T : a peer-reviewed journal for formulary management,
I I Miagkov, and V R Trotsiuk
January 1992, The Clinical investigator,
I I Miagkov, and V R Trotsiuk
March 1988, The Medical letter on drugs and therapeutics,
I I Miagkov, and V R Trotsiuk
February 1991, Annals of the rheumatic diseases,
I I Miagkov, and V R Trotsiuk
December 1996, Chest,
I I Miagkov, and V R Trotsiuk
May 1990, Experimental eye research,
I I Miagkov, and V R Trotsiuk
January 1990, Voprosy onkologii,
Copied contents to your clipboard!